These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22607487)

  • 1. Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up.
    Polasek R; Kucera P; Nedbal P; Roubicek T; Belza T; Hanuliakova J; Horak D; Wichterle D; Kautzner J
    BMC Cardiovasc Disord; 2012 May; 12():34. PubMed ID: 22607487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of measures of ventricular delay on cardiac resynchronization therapy response.
    Field ME; Yu N; Wold N; Gold MR
    Heart Rhythm; 2020 Apr; 17(4):615-620. PubMed ID: 31765805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density epicardial activation mapping to optimize the site for video-thoracoscopic left ventricular lead implant.
    Polasek R; Skalsky I; Wichterle D; Martinca T; Hanuliakova J; Roubicek T; Bahnik J; Jansova H; Pirk J; Kautzner J
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):882-888. PubMed ID: 24724625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
    PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With Cardiac Resynchronization Therapy.
    Roubicek T; Wichterle D; Kucera P; Nedbal P; Kupec J; Sedlakova J; Cerny J; Stros J; Kautzner J; Polasek R
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1113-21. PubMed ID: 26338831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.
    Engels EB; Végh EM; Van Deursen CJ; Vernooy K; Singh JP; Prinzen FW
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):176-83. PubMed ID: 25230363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.
    Sommer A; Kronborg MB; Nørgaard BL; Stephansen C; Poulsen SH; Kristensen J; Gerdes C; Nielsen JC
    Europace; 2018 Oct; 20(10):1630-1637. PubMed ID: 29377984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
    Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programming Cardiac Resynchronization Therapy for Electrical Synchrony: Reaching Beyond Left Bundle Branch Block and Left Ventricular Activation Delay.
    Varma N; O'Donnell D; Bassiouny M; Ritter P; Pappone C; Mangual J; Cantillon D; Badie N; Thibault B; Wisnoskey B
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29432133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
    van Everdingen WM; Zweerink A; Cramer MJ; Doevendans PA; Nguyên UC; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005912. PubMed ID: 29874169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrioventricular optimization in cardiac resynchronization therapy with quadripolar leads: should we optimize every pacing configuration including multi-point pacing?
    van Everdingen WM; Zweerink A; Salden OAE; Cramer MJ; Doevendans PA; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Europace; 2019 Jan; 21(1):e11-e19. PubMed ID: 30052906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.
    Gold MR; Yu Y; Singh JP; Birgersdotter-Green U; Stein KM; Wold N; Meyer TE; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006055. PubMed ID: 30354310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
    Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
    BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved patient selection for cardiac resynchronization therapy by normalization of QRS duration to left ventricular dimension.
    Zweerink A; Wu L; de Roest GJ; Nijveldt R; de Cock CC; van Rossum AC; Allaart CP
    Europace; 2017 Sep; 19(9):1508-1513. PubMed ID: 27707784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring device settings in cardiac resynchronization therapy using electrograms from pacing electrodes.
    Engels EB; Mafi-Rad M; Hermans BJM; Aranda A; van Stipdonk AMW; Rienstra M; Scheerder COS; Maass AH; Prinzen FW; Vernooy K
    Europace; 2018 Jul; 20(7):1146-1153. PubMed ID: 29106563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.